SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-21-030025
Filing Date
2021-03-01
Accepted
2021-03-01 16:31:55
Documents
10
Effectiveness Date
2021-03-01

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm217929-2_s3asr.htm S-3ASR 504892
2 EXHIBIT 4.4 tm2179293c1_ex4-4.htm EX-4.4 364059
3 EXHIBIT 4.5 tm2179293c1_ex4-5.htm EX-4.5 402412
4 EXHIBIT 4.6 tm2179293c1_ex4-6.htm EX-4.6 44337
5 EXHIBIT 4.7 tm2179293c1_ex4-7.htm EX-4.7 44498
6 EXHIBIT 5.1 tm2179293c1_ex5-1.htm EX-5.1 43395
7 EXHIBIT 23.1 tm2179293c1_ex23-1.htm EX-23.1 2781
8 GRAPHIC lg_editasmedicine-4c.jpg GRAPHIC 46317
9 GRAPHIC img001_v1.jpg GRAPHIC 3400
10 GRAPHIC img002_v1.jpg GRAPHIC 16697
  Complete submission text file 0001104659-21-030025.txt   1498817
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-253715 | Film No.: 21698352
SIC: 2836 Biological Products, (No Diagnostic Substances)